Dermisonics, Inc. DMSI

Company Overview

Dermisonics, Inc. (OTC: DMSI) is a publicly traded micro-cap company historically associated with ultrasound-enabled transdermal drug delivery technology and related medical device development. Based on available public disclosures and OTC market information, the company has explored technologies designed to improve the delivery of pharmaceuticals through the skin using low-frequency ultrasound methods. Publicly available information indicates the company has operated within the broader healthcare technology and medical device industries, though current commercial scale, revenue generation, and operational status are not consistently verified across recent filings and market databases.

Historically, Dermisonics sought to position itself within non-invasive drug delivery and therapeutic technology markets by developing proprietary ultrasound applications intended to enhance absorption of topical medications. However, recent independently verifiable operational disclosures appear limited, and publicly accessible financial and operational reporting is incomplete compared with larger SEC-reporting issuers. Data regarding current products, active commercialization efforts, and revenue concentration is inconclusive based on available public sources.